StockData
Fulgent Genetics, Inc. logo

Fulgent Genetics, Inc. (FLGT) stock

FLGTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3047% below fair value
$25.13+0.92 (+3.80%)

Close on Nov 18, 2026Market cap $691.46MP/E –Yield –

Fulgent Genetics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Fulgent Genetics's revenue for the twelve months ending Jun 30, 2026 was $323.93M, up 6.8% year over year. For fiscal 2025 it was $322.67M, up 13.8% from the year before. Over ten years it grew 42.2% a year on average. The highest annual figure on record is $992.58M in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$322.67M+13.8%
FY2024Dec 31, 2024$283.47M-2.0%
FY2023Dec 31, 2023$289.21M-53.3%
FY2022Dec 31, 2022$618.97M-37.6%
FY2021Dec 31, 2021$992.58M+135.4%
FY2020Dec 31, 2020$421.71M+1196.5%
FY2019Dec 31, 2019$32.53M+52.3%
FY2018Dec 31, 2018$21.35M+14.0%
FY2017Dec 31, 2017$18.73M+2.5%
FY2016Dec 31, 2016$18.28M+90.9%
FY2015Dec 31, 2015$9.58M+649.3%
FY2014Dec 31, 2014$1.28M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$85.39M+4.4%
Q1 FY2026Mar 31, 2026$71.14M-3.2%
Q4 FY2025Dec 31, 2025$83.34M+9.3%
Q3 FY2025Sep 30, 2025$84.07M+17.2%
Q2 FY2025Jun 30, 2025$81.80M+15.2%
Q1 FY2025Mar 31, 2025$73.46M+13.9%
Q4 FY2024Dec 31, 2024$76.21M+8.1%
Q3 FY2024Sep 30, 2024$71.74M-15.3%
Q2 FY2024Jun 30, 2024$71.03M+4.7%
Q1 FY2024Mar 31, 2024$64.49M-2.5%
Q4 FY2023Dec 31, 2023$70.51M+4.1%
Q3 FY2023Sep 30, 2023$84.69M-19.8%
Q2 FY2023Jun 30, 2023$67.85M-45.9%
Q1 FY2023Mar 31, 2023$66.17M-79.3%
Q4 FY2022Dec 31, 2022$67.70M-73.1%
Q3 FY2022Sep 30, 2022$105.66M-53.6%
Q2 FY2022Jun 30, 2022$125.34M-18.4%
Q1 FY2022Mar 31, 2022$320.27M-10.9%
Q4 FY2021Dec 31, 2021$251.67M-14.7%
Q3 FY2021Sep 30, 2021$227.87M+124.0%
Q2 FY2021Jun 30, 2021$153.62M+789.8%
Q1 FY2021Mar 31, 2021$359.43M+4536.0%
Q4 FY2020Dec 31, 2020$294.98M+3417.1%
Q3 FY2020Sep 30, 2020$101.72M+883.0%
Q2 FY2020Jun 30, 2020$17.27M+105.0%
Q1 FY2020Mar 31, 2020$7.75M+44.4%
Q4 FY2019Dec 31, 2019$8.39M+47.8%
Q3 FY2019Sep 30, 2019$10.35M+83.9%
Q2 FY2019Jun 30, 2019$8.42M+56.0%
Q1 FY2019Mar 31, 2019$5.37M+15.4%
Q4 FY2018Dec 31, 2018$5.67M+32.5%
Q3 FY2018Sep 30, 2018$5.63M+24.9%
Q2 FY2018Jun 30, 2018$5.40M+16.4%
Q1 FY2018Mar 31, 2018$4.65M-12.3%
Q4 FY2017Dec 31, 2017$4.28M-26.9%
Q3 FY2017Sep 30, 2017$4.50M-10.1%
Q2 FY2017Jun 30, 2017$4.64M–
Q1 FY2017Mar 31, 2017$5.31M–
Q4 FY2016Dec 31, 2016$5.85M–
Q3 FY2016Sep 30, 2016$5.01M–

More Fulgent Genetics figures

See a number that looks wrong?